Gloria Melanie — SEC insider filings
SEC reporting owner CIK 1973838. 17 insider filings on record with FilingPulse; latest filed 2026-10-09.
Transaction summary — filings shown
Covers all 17 filings on record, filed 2023-05-04 to 2026-10-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 15 legs across 8 filings — 52,748 shares, $1,671,996 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 17.
- Largest priced transaction: sale of 14,748 shares @ $38.18 ($563,079) in Immunovant, Inc., filed 2026-06-26.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Immunovant, Inc. (IMVT) | Chief Operating Officer | 11 | — | 15 legs · 52,748 sh · $1,671,996 | 6 |
| ACELYRIN, Inc. (SLRN) | Chief Operating Officer | 6 | — | — | 11 |
Insider filings — Gloria Melanie
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-09 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 2,241 @ $32.06 | EDGAR |
| 2026-08-21 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 3,056 @ $44.16 | EDGAR |
| 2026-07-10 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 1,930 @ $39.53 · Sale (S): 106 @ $39.99 | EDGAR |
| 2026-06-26 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 14,748 @ $38.18 · Sale (S): 2,966 @ $38.95 | EDGAR |
| 2026-05-22 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 249 @ $30.41 · Sale (S): 1,168 @ $32.15 · Sale (S): 1,698 @ $32.95 | EDGAR |
| 2026-04-10 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 8,722 @ $24.83 | EDGAR |
| 2026-04-09 | 4 | Immunovant, Inc. (IMVT) | Grant/award (A): 83,671 @ $0 · Grant/award (A): 121,063 (derivative) @ $0 | EDGAR |
| 2026-02-27 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 1,437 @ $26.98 · Sale (S): 859 @ $28.16 · Sale (S): 942 @ $28.90 | EDGAR |
| 2025-11-21 | 4 | Immunovant, Inc. (IMVT) | Sale (S): 10,251 @ $23.54 · Sale (S): 2,375 @ $23.97 | EDGAR |
| 2025-04-03 | 4 | Immunovant, Inc. (IMVT) | Grant/award (A): 76,181 @ $0 · Grant/award (A): 107,297 (derivative) @ $0 | EDGAR |
| 2024-11-20 | 4 | Immunovant, Inc. (IMVT) | Grant/award (A): 109,956 @ $0 · Grant/award (A): 137,446 (derivative) @ $0 | EDGAR |
| 2024-05-24 | 4 | ACELYRIN, Inc. (SLRN) | Grant/award (A): 184,042 (derivative) @ $0 | EDGAR |
| 2024-05-17 | 4 | ACELYRIN, Inc. (SLRN) | Tax withholding (F): 10,298 @ $4.47 | EDGAR |
| 2024-01-11 | 4 | ACELYRIN, Inc. (SLRN) | Grant/award (A): 494,297 (derivative) @ $0 | EDGAR |
| 2023-08-18 | 4 | ACELYRIN, Inc. (SLRN) | Grant/award (A): 140,584 @ $0 | EDGAR |
| 2023-05-11 | 4 | ACELYRIN, Inc. (SLRN) | Other (J): 330,181 (derivative) @ $0 · Other (J): 330,181 (derivative) @ $0 · Other (J): 187,988 (derivative) @ $0 · Other (J): 187,988 (derivative) @ $0 · Other (J): 232,436 (derivative) @ $0 · Other (J): 232,436 (derivative) @ $0 | EDGAR |
| 2023-05-04 | 4 | ACELYRIN, Inc. (SLRN) | Grant/award (A): 232,436 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2022-05-23 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1973838 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs